Global Cord Blood Corp
US ˙ NYSE
DETTE SYMBOL ER IKKE LÆNGERE AKTIVT

SecurityCO / Global Cord Blood Corp
InstitutionGLG Partners LP
ManagerNoam Gottesman
Latest Disclosed Ownership638,136 shares
Latest Disclosed Value $ 6,349,000
GLG Partners LP reports 4.59% decrease in ownership of CO / Global Cord Blood Corp

On February 14, 2018 - GLG Partners LP filed a 13F-HR form disclosing ownership of 638,136 shares of Global Cord Blood Corp (US:CO) valued at $6,349,453 USD as of December 31, 2017. The entity filed a previous 13F-HR on November 14, 2017 disclosing 668,823 shares of Global Cord Blood Corp. This represents a change in shares of -4.59% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2018-02-14 2017-12-31 13F CHINA CORD BLOOD SHS G21107100 638,136 -30,687 -4.59 6,349 -14.64 0.2969
2017-11-14 2017-09-30 13F CHINA CORD BLOOD SHS G21107100 668,823 -841,490 -55.72 7,438 -48.05 0.3941
2017-08-14 2017-06-30 13F CHINA CORD BLOOD SHS G21107100 1,510,313 -96,855 -6.03 14,318 33.78 0.7919
2017-05-15 2017-03-31 13F CHINA CORD BLOOD SHS G21107100 1,607,168 -1,220 -0.08 10,703 8.74 0.4999
2017-02-14 2016-12-31 13F CHINA CORD BLOOD SHS G21107100 1,608,388 577,518 56.02 9,843 86.85 0.3927
2016-11-14 2016-09-30 13F CHINA CORD BLOOD SHS G21107100 1,030,870 106,939 11.57 5,268 -0.85 0.1622
2016-08-15 2016-06-30 13F CHINA CORD BLOOD SHS G21107100 923,931 19,800 2.19 5,313 -3.19
2016-05-16 2016-03-31 13F CHINA CORD BLOOD SHS G21107100 904,131 136,669 17.81 5,488 12.25 0.1556
2016-02-16 2015-12-31 13F CHINA CORD BLOOD SHS G21107100 767,462 562,529 274.49 4,889 296.19 0.1555
2015-11-16 2015-09-30 13F CHINA CORD BLOOD SHS G21107100 204,933 204,933 1,234 0.0326
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.